Business RadioX

/in , /by


Atlanta, GA (PRWEB) January 10, 2014

On January 7, 2014, co-hosts Lee Kantor and Stone Payton of Results Matter Radio on Business RadioX® sat down with Elan Amram from CrowdFundBeat and David Lilenfeld from SterlingFunder to discuss the recent rise of crowdfunding.

Elan Amram is Founder and CEO at SchmoozBiz, a social networking destination devoted to the crowdfunding community. As a contributor to CrowdFundBeat, Amram is also involved in the CrowdFunding USA Conference & Expo, happening in Atlanta May 1-2, 2014. According to Amram, “CrowdFunding USA provides the participants with the unique opportunity to discuss the current state of the industry, to learn from experts in venture capital, business angel and crowdfunding fields, to network and find new partnerships.”

Also in the studio was David Lilenfeld, Co-Founder and CEO of SterlingFunder, an Atlanta-based equity and debt crowdfunding portal with an innovative approach to connecting startup companies seeking capital with qualified investors. As a lawyer, investor and entrepreneur, Lilenfeld recognizes the enormous effect crowdfunding will have on businesses and individual investors across the country and eventually the world. Explained Lilenfeld, “When The JOBS Act – which makes equity-based crowdfunding legal in the United States – became law, I began planning a way to help match passionate, smart entrepreneurs with intelligent, growth-minded investors in a union that has been unduly burdensome to make before crowdfunding.”

To learn more about crowdfunding, the upcoming Conference & Expo and these featured guests, listen to the complete interview on Results Matter Radio.

About Burr & Forman’s Results Matter Radio: http://resultsmatterradio.businessradiox.com/

Brought to you by Burr & Forman LLP, Results Matter Radio brings you pertinent business information and real life solutions to help drive desired results – whatever your business may be. We interview Business Leaders and Trusted Advisors about the most important issues in Commercial Real Estate, International Commerce, Healthcare, Family Business, Corporate Litigation, Finance, Philanthropy, Estate Planning, and more.

About Business RadioX®:

BusinessRadioX® interviews dozens of innovative entrepreneurs and successful leaders each week. Its mission is to help local businesses Get The Word Out about the important work they’re doing for their market, their community, and their profession. With a pro-business slant and a long-form interview format, guests don’t have to worry about being ambushed or talking in “sound bites.” Guests have enough time to tell their whole story and to share their insights and experience without interruptions. BusinessRadioX® hosts are business professionals interviewing their peers, drilling down on the critical issues, and delivering practical information to an engaged business audience. Business topics that are frequently covered include: Law, Finance, Healthcare, Technology, Trade Shows, B2B Marketing, Venture Capital, Training and Development and other issues impacting the business community. For more information, visit: http://www.businessradiox.com.







Venture capital in Italia: Enrico Gasperini e l'incubatore Digital Magics

/in , /by

Venture capital in Italia: Enrico Gasperini e l'incubatore Digital Magics

Digital Magics incubatore attivo da anni nel campo delle startup si presenta con un evento a Milano. Enrico Gasperini che l’ha fondato parla di innovazione …
Video Rating: 5 / 5

Beth Seidenberg, Kleiner Perkins, on Training for Success in Venture Capital for Women

/in , /by

Video interview with Beth Seidenberg,MD, http://www.kpcb.com/team/index.php?Beth%20Seidenberg,%20M.D. partner @ Kleiner Perkins Caufield and Byers. Beth join…
Video Rating: 5 / 5

The Atlanta, Georgia G3 Chocolatier Association Reports that Seattle Food Scientist, Terry Wakefield, Completed a 3rd Party Fact Analysis of Xocai Healthy Dark Cacao

/in , /by


(PRWEB) January 08, 2014

Modern food scientists and technologists are flexible, interdisciplinary and joint practitioners in a profession at the junction of scientific and technological developments. As food system has radically changed, from one centered around family food production and preservation on individual farms to the modern system of today, most people are no longer connected to their food nor are they familiar with the agricultural production and food manufacturing processes designed for providing higher quality, safe food. In the United States, food science is typically studied at “land-grant” universities, which were chartered in the mid-1800’s to support agricultural and technical education.

Thanks to a new friend, Adam Paul Green of Atlanta, Georgia G3 Chocolatier Association, Terry Wakefield discovered “Xocai” and became intrigued.

Terry Wakefield quote: “In my case, I went to school at Oregon State University located in Corvallis, Oregon http://oregonstate.edu/dept/foodsci/. A food science and engineering curriculum is an eclectic mix of “hard” and “soft” science — chemistry, biology, economics, microbiology, statistics, nutrition and engineering blended together with the culinary arts. Upon my graduation, I went to work for General Foods (currently part of Kraft) as a quality control supervisor. I quickly moved into a plant quality control manager position and then on into corporate quality assurance where I was responsible for helping assure that all of the company’s production facilities met standards and that key ingredient suppliers were in compliance with specifications. I was then promoted to quality control manager of a large plant where I was also on the original product development and commercialization team for Cool Whip.”

http://oregonstate.edu/foodsci/

“My next assignment was in Delaware as quality control manager for a 27 acre production facility which produced a broad array of products (Minute Rice, Minute Tapioca, Baker’s Coconut, Log Cabin Syrup, Dream Whip, Kool-Aid, Jell-O Gelatin & Pudding, Stove Top Stuffing and Baker’s Chocolate). With chocolate back in my life, I was able to transition out of the quality control arena and into production management. I was responsible for producing most of the products noted above, but my favorite assignment was running the 6.5 acre chocolate manufacturing facility. We had 40 silos (each held 1 million pounds) for storing cocoa beans so I had access to beans from virtually every part of the world (Madagascar, Bahia, Sanchez, Samoa, Ghana, Maracaibo, Arriba, etc.). I have also had a privilege to work for Bissinger’s Handcrafted Chocolates in St. Louis as Senior VP and Chief Chocolatier. This very old chocolate company had originally made chocolate for King Louis XIV,” says Terry Wakefield.

Terry Wakefield

terryw934(at)gmail(dot)com

http://cacaopow.youthfulchocolate.com/

Discovery IFT Food Science

http://www.dailymotion.com/video/x9gnzr_discovery-ift-food-science_shortfilms

About Us

G3 Development is set out to proactively serve the business community by providing solutions in entrepreneurialism, business development, social media and venture capitalism.

To provide leadership in establishing strength with our client’s international businesses, being built on a foundation of innovation, advocacy, technology and business integrity

1-877-229-9183







More Venture Capital Press Releases

Benchmark's Bill Gurley on Opportunities for venture capital

/in , /by

What are the trends shaping VC investment right now.
Video Rating: 0 / 5

Komisar believes that the ability and commitment to building businesses rather than just investing in it is what makes successful venture capital firms.
Video Rating: 0 / 5

Ann Miura-Ko: The Entrepreneurship of Venture Capital

/in , /by

Ann Miura-Ko shares the origin story of FLOODGATE Fund, where she is a co-founding partner with angel investor Mike Maples. In this poignant clip, Miura-Ko s…
Video Rating: 5 / 5

Militello Capital Invests in Fitness App, Nexercise

/in , /by


Leesburg, VA (PRWEB) January 06, 2014

The idea of Nexercise was conceived when CEO & Founder, Benjamin Young, needed an easier way to maintain his weight on top of his busy schedule. With the help of Co-Founders, Greg Coleman and Boomie Odumade, the fitness app was developed. The trio diligently leads the Nexercise team who strive to make healthy lifestyles attainable. Great leadership is no stranger to Greg who serves as Lieutenant Colonel and Command Pilot in the Air National Guard during the short periods of time he’s away.

The free Nexercise iPhone and Android app delivers physical rewards in two ways. It motivates those who want to lose weight and maintain a healthier lifestyle in a fun and manageable approach. Like frequent flyer miles, users accumulate points through physical activity which can be converted into real rewards like gift cards with Starbucks, iTunes, or Amazon. Users can even donate to charitable causes. For added motivation, individuals have the ability to compete with friends and family with similar health goals.

According to Matt Brady, Co-Founder and COO of Militello Capital, “It is a pleasure to work with entrepreneurs who are committed to building a company whose success can be measured both in terms of bottom line performance and impact on its community. We believe Nexercise fits perfectly into our portfolio.”

“We are very excited to have Militello Capital on board. They are true partners with the companies they work with and not just passive investors. Just weeks after closing our round they were already making introductions on our behalf.”

Nexercise is a mobile platform that uses friendly competition and real rewards to motivate busy people to lose weight and stay fit. This platform is also the easiest way on the market to set up wellness challenges between groups of friends and/or co-workers, because it’s quick to learn and fun to play. Nexercise is positioned to become the premier brand associated with sustained motivation for a healthy lifestyle.

Militello Capital

Militello Capital is a Northern Virginia-based private equity investment manager. We’ve moved beyond Wall Street to a place where ideas matter, people have names and investing is as much about creating opportunity as it is about increasing wealth. Our firm was founded on the principle that true wealth is created in private investments. We offer two distinct alternative investment strategies available exclusively through certified RIAs: deep value commercial real estate and emerging technology venture capital.

Visit http://www.militellocapital.com/ to learn more.

The information contained herein should not be construed as personalized investment advice. Investing in venture capital companies involves some degree of risk and may not be suitable for all investors. Information presented herein is subject to change without notice and should not be considered as a solicitation to buy or sell any security. The companies highlighted above are not necessarily the highest performing investments in the fund, but are noted as purchases made to date. The reader should not assume that investments in the companies identified were or will be profitable.







Find More Venture Capital Press Releases

New Models for Venture Capital Funding 2

/in , /by

New Models for Venture Capital Funding 2 from Business Innovation Factory. Like this? Watch the latest episode of Business Innovation Factory on Blip! http:/…

Latest Venture Capital News

/in , /by

Venture Capital World Summit Presentation

Image by YODspica
Event before the Grand on the 19-20th September 2013, photos taken on 28th August 2013 by ZoomBox.co.uk Studios (Robyn Saunders) at the Grosvenor Casino Cardiff Bay

Soft Tissue Regeneration, Inc. Announces Financing and Appoints New Members to Board of Directors

/in , /by


New Haven, Conn. (PRWEB) January 06, 2014

Soft Tissue Regeneration, Inc. (“STR”), a developer of regenerative orthopedic devices for tendon and ligament repair, today announced the completion of a financing and the addition of three new members to the company’s board of directors. The $ 5 million financing commitment will permit STR to complete its European Phase I clinical study and continue the FDA regulatory process for the Company’s L-C Ligament®, a bioresorbable, implantable scaffold for the repair and regeneration of an injured or torn anterior cruciate ligament (“ACL”). In conjunction with this financing, Dane Miller, Ph.D., Charles Hart, Ph.D., and Richard Emmitt are joining the STR board of directors, offering deep industry expertise in medical devices and investments.

Current investors, Connecticut Innovations and Launch Capital, led the $ 5 million financing and Dane Miller and The Vertical Group also participated. The financing allows STR to complete its 15-patient Phase I clinical study of the L-C Ligament in Europe, which enrolled the first patient in June, 2013, in The Netherlands. The financing will also support STR’s continued regulatory and clinical activities with the United States Food and Drug Administration (FDA) in preparation for a global pivotal clinical trial. The first tranche of STR’s $ 5 million financing closed on Nov. 19, 2013.

“STR has quickly progressed from a concept to a real product that is already demonstrating clinically its potential to provide surgeons and their ACL patients with an alternative to the inherent morbidity and risks of autograft or allograft tendon,” said Joseph Reilly, president, CEO, and co-founder of STR. “The new members of the board of directors offer years of experience and the guidance and insight that will allow us to continue making clinical and regulatory advances.”

The new members to the STR board of directors include:

Dane Miller, Ph.D. – Miller is the founder, current member of the board of directors, and former president and CEO of Biomet, a pioneer and leading company in the orthopedic industry. Miller offers insights and knowledge from his more than 40 years of experience and is considered one of the most distinguished entrepreneurs and executives in the medical device industry.

Charles Hart, Ph.D. – Hart is the former chief scientific officer and vice president of two of the pioneers in the field of regenerative medical technology, Advanced BioHealing and BioMimetics. He has more than 30 years of experience in commercializing advances in biomaterials and biotechnology.

Richard Emmitt – Emmitt is a general partner with The Vertical Group, a leading venture capital firm focused on the medical device industry. During his 40-year career, he has invested in and served as a member of the board of directors at several of the most successful medical device companies.

About STR and the L-C Ligament: Soft Tissue Regeneration, Inc. is a medical device company focused on the application of resorbable polymer scaffold technology to address unmet needs of surgeons and their patients. The Company’s devices are based on proprietary fiber, braid and mesh designs comprised of poly (L) lactic acid (“PLLA”), a resorbable polymer with a long and proven history of use in implantable medical devices. The STR device designs are ideally suited for tendon, ligament, and other soft tissue injuries when an implantable scaffold is required for the reinforcement and/or regeneration of functional tissue. The first STR device to reach the clinical stage is the L-C Ligament. This device has the potential to advance the surgical repair of torn ACL’s by obviating the need to utilize either the patient’s own tissue (“autograft”) with the pain and morbidity of a second surgical site, or the use of cadaver tissue (“allograft”) with the risks of infection and sub-optimal healing. Following three years of animal testing that has demonstrated the ability of the L-C Ligament to remodel and regenerate functioning ligament, STR has initiated a 15 patient Phase I clinical study in Europe. The first patient was treated in June, 2013 in Zwolle, The Netherlands and, as of this date, the 10 patients that have received L-C Ligament implants are all doing well.







More Venture Capital Press Releases